Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.

Grinsztejn B, Hughes MD, Ritz J, Salata R, Mugyenyi P, Hogg E, Wieclaw L, Gross R, Godfrey C, Cardoso SW, Bukuru A, Makanga M, Faesen S, Mave V, Wangari Ndege B, Nerette Fontain S, Samaneka W, Secours R, van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, Sugandhavesa P, Montalban E, Avihingsanon A, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC; A5288 Team.

Lancet HIV. 2019 Jul 29. pii: S2352-3018(19)30146-8. doi: 10.1016/S2352-3018(19)30146-8. [Epub ahead of print]

PMID:
31371262
2.

Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.

Thomas BE, Thiruvengadam K, S R, Kadam D, Ovung S, Sivakumar S, Bala Yogendra Shivakumar SV, Paradkar M, Gupte N, Suryavanshi N, Dolla CK, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Chandrasekaran P, Gupta A; CTRIUMPH-RePORT India Study.

PLoS One. 2019 Jul 31;14(7):e0220507. doi: 10.1371/journal.pone.0220507. eCollection 2019.

3.

Infection free "resisters" among household contacts of adult pulmonary tuberculosis.

Mave V, Chandrasekaran P, Chavan A, Shivakumar SVBY, Danasekaran K, Paradkar M, Thiruvengadam K, Kinikar A, Murali L, Gaikwad S, Hanna LE, Kulkarni V, Pattabiraman S, Suryavanshi N, Thomas B, Kohli R, Sivaramakrishnan GN, Pradhan N, Bhanu B, Kagal A, Golub J, Gandhi N, Gupte A, Gupte N, Swaminathan S, Gupta A; CTRIUMPH RePORT India Study Team.

PLoS One. 2019 Jul 18;14(7):e0218034. doi: 10.1371/journal.pone.0218034. eCollection 2019.

4.

High risk for latent tuberculosis infection among medical residents and nursing students in India.

Kinikar A, Chandanwale A, Kadam D, Joshi S, Basavaraj A, Pardeshi G, Girish S, Shelke S, DeLuca A, Dhumal G, Golub J, Lokhande N, Gupte N, Gupta A, Bollinger R, Mave V.

PLoS One. 2019 Jul 8;14(7):e0219131. doi: 10.1371/journal.pone.0219131. eCollection 2019.

5.

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.

Dooley KE, Hanna D, Mave V, Eisenach K, Savic RM.

PLoS Med. 2019 Jul 5;16(7):e1002842. doi: 10.1371/journal.pmed.1002842. eCollection 2019 Jul. No abstract available.

6.

A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries.

Cotton MF, Rabie H, Nemes E, Mujuru H, Bobat R, Njau B, Violari A, Mave V, Mitchell C, Oleske J, Zimmer B, Varghese G, Pahwa S; P1073 team.

PLoS One. 2019 Jul 1;14(7):e0211155. doi: 10.1371/journal.pone.0211155. eCollection 2019.

7.

High prevalence of insulin resistance and occurrence prior to hyperinsulinemia threshold among people living with HIV in Pune, India.

Marbaniang I, Sangle S, Salvi S, Kulkarni V, Shere D, Deshpande P, Nimkar S, Gupta A, Mave V.

Diabetes Metab Syndr. 2019 May - Jun;13(3):1813-1819. doi: 10.1016/j.dsx.2019.04.009. Epub 2019 Apr 13.

PMID:
31235099
8.

Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy?

Dolla CK, Padmapriyadarsini C, Thiruvengadam K, Lokhande R, Kinikar A, Paradkar M, Bm S, Murali L, Gupte A, Gaikwad S, Selvaraju S, Padmanaban Y, Pattabiraman S, Pradhan N, Kulkarni V, Shivakumar SVBY, Prithivi M, Kagal A, Karthavarayan BT, Suryavanshi N, Gupte N, Kumaran P, Mave V, Gupta A.

Trans R Soc Trop Med Hyg. 2019 Jun 21. pii: trz049. doi: 10.1093/trstmh/trz049. [Epub ahead of print]

PMID:
31225622
9.

Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.

Gupte AN, Paradkar M, Selvaraju S, Thiruvengadam K, Shivakumar SVBY, Sekar K, Marinaik S, Momin A, Gaikwad A, Natrajan P, Prithivi M, Shivaramakrishnan G, Pradhan N, Kohli R, Raskar S, Jain D, Velu R, Karthavarayan B, Lokhande R, Suryavanshi N, Gupte N, Murali L, Salvi S, Checkley W, Golub J, Bollinger R, Mave V, Padmapriyadarasini C, Gupta A.

PLoS One. 2019 May 23;14(5):e0217289. doi: 10.1371/journal.pone.0217289. eCollection 2019.

10.

Sub-therapeutic rifampicin concentration is associated with unfavourable tuberculosis treatment outcomes.

Ramachandran G, Chandrasekaran P, Gaikwad S, Hemanth Kumar AK, Thiruvengadam K, Gupte N, Paradkar M, Dhanasekaran K, Sivaramakrishnan GN, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V; C-TRIUMPh team.

Clin Infect Dis. 2019 May 10. pii: ciz380. doi: 10.1093/cid/ciz380. [Epub ahead of print]

PMID:
31075166
11.

Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.

Gupte AN, Selvaraju S, Paradkar M, Danasekaran K, Shivakumar SVBY, Thiruvengadam K, Dolla C, Shivaramakrishnan G, Pradhan N, Kohli R, John S, Raskar S, Jain D, Momin A, Subramanian B, Gaikwad A, Lokhande R, Suryavanshi N, Gupte N, Salvi S, Murali L, Checkley W, Golub JE, Bollinger R, Chandrasekaran P, Mave V, Gupta A.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):450-457. doi: 10.5588/ijtld.18.0551.

PMID:
31064624
12.

Feasibility of Identifying Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, Dawson R, Mave V, Sanchez J, Mendoza A, Gonzales P, Kumarasamy N, Comins K, Conradie F, Shenje J, Fontain SN, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo UG, Ferreira ACG, Mugah C, Harrington M, Jones L, Cox S, Smith B, Shah NS, Hesseling AC, Churchyard G; ACTG 5300/IMPAACT I2003 PHOENIx Feasibility study team.

Clin Infect Dis. 2019 Mar 28. pii: ciz235. doi: 10.1093/cid/ciz235. [Epub ahead of print]

PMID:
30942853
13.

Willingness to Take Multidrug-Resistant Tuberculosis (MDR-TB) Preventive Therapy among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multi-Site Cross-Sectional Study.

Suryavanshi N, Murrill M, Gupta A, Hughes M, Hesseling A, Kim S, Naini L, Jones L, Smith B, Gupte N, Dawson R, Mave V, Meshram S, Mendoza-Ticona A, Sanchez J, Kumarasamy N, Comins K, Conradie F, Shenje J, Nerette Fontain S, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo U, Ferreira ACG, Okeyo E, Swindells S, Churchyard G, Shah NS; A5300/I2003 Study Team.

Clin Infect Dis. 2019 Mar 28. pii: ciz254. doi: 10.1093/cid/ciz254. [Epub ahead of print]

PMID:
30919881
14.

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.

Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS; IMPAACT PROMISE 1077BF/FF team.

HIV Clin Trials. 2018 Dec;19(6):209-224. doi: 10.1080/15284336.2018.1537327.

PMID:
30890061
15.

Elevated highly sensitive C-reactive protein and d-dimer levels are associated with food insecurity among people living with HIV in Pune, India.

Patil S, Kadam D, Mehtani N, Sangle S, Marbaniang I, Kulkarni V, Shere D, Deshpande P, Dhumal G, Suryavanshi N, Gupte N, Bollinger R, DeLuca A, Nevrekar N, Menon P, Kawade R, Patil M, Gupta A, Mave V.

Public Health Nutr. 2019 Aug;22(11):2022-2029. doi: 10.1017/S136898001900020X. Epub 2019 Mar 4.

16.

HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.

Opollo VS, Wu X, Hughes MD, Swindells S, Gupta A, Hesseling A, Churchyard G, Kim S, Lando R, Dawson R, Mave V, Mendoza A, Gonzales P, Kumarasamy N, von Groote-Bidlingmaier F, Conradie F, Shenje J, Fontain SN, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Mngqibisa R, Garcia Ferreira AC, Okeyo E, Naini L, Jones L, Smith B, Shah NS.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1443-1449. doi: 10.5588/ijtld.18.0108.

PMID:
30606316
17.

Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C.

Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009. Epub 2018 Oct 1.

PMID:
30514497
18.

Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India.

Bharadwaj R, Robinson ML, Balasubramanian U, Kulkarni V, Kagal A, Raichur P, Khadse S, Kadam D, Valvi C, Kinikar A, Kanade S, Suryavanshi N, Marbaniang I, Nelson G, Johnson J, Zenilman J, Sachs J, Gupta A, Mave V.

BMC Infect Dis. 2018 Oct 4;18(1):504. doi: 10.1186/s12879-018-3390-4.

19.

The association of household fine particulate matter and kerosene with tuberculosis in women and children in Pune, India.

Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Paradkar M, Kulkarni V, Pradhan N, Breysse PN, Gupta A, Golub JE.

Occup Environ Med. 2019 Jan;76(1):40-47. doi: 10.1136/oemed-2018-105122. Epub 2018 Sep 7.

PMID:
30194271
20.

Challenges and opportunities for outreach workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) program in India.

Suryavanshi N, Mave V, Kadam A, Kanade S, Sivalenka S, Kumar VS, Harvey P, Gupta R, Hegde A, Gupte N, Gupta A, Bollinger RC, Shankar A.

PLoS One. 2018 Sep 4;13(9):e0203425. doi: 10.1371/journal.pone.0203425. eCollection 2018.

21.

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Chon S, Gupta A, Golub JE, Dooley KE.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01383-18. doi: 10.1128/AAC.01383-18. Print 2018 Nov.

22.

Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).

Swindells S, Gupta A, Kim S, Hughes MD, Sanchez J, Mave V, Dawson R, Kumarasamy N, Comins K, Smith B, Rustomjee R, Naini L, Shah NS, Hesseling A, Churchyard G.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1016-1022. doi: 10.5588/ijtld.18.0163.

23.

Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.

Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A; CTRIUMPH Study Team.

PLoS One. 2018 Aug 1;13(8):e0199360. doi: 10.1371/journal.pone.0199360. eCollection 2018.

24.

Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):800-806. doi: 10.5588/ijtld.18.0026.

25.

Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?

Shivakumar SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavarshini N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Sivaramakrishnan GN, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bhardawaj R, Bollinger RC, Golub J, Selvaraj K, Gupte N, Swaminathan S, Mave V, Gupta A.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):686-694. doi: 10.5588/ijtld.17.0598.

PMID:
29862955
26.

Sources of household air pollution and their association with fine particulate matter in low-income urban homes in India.

Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Breysse PN, Gupta A, Golub JE.

J Expo Sci Environ Epidemiol. 2018 Jun;28(4):400-410. doi: 10.1038/s41370-018-0024-2. Epub 2018 May 23.

27.

Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination.

DeLuca A, Dhumal G, Paradkar M, Suryavanshi N, Mave V, Kohli R, Shivakumar SVBY, Hulyolkar V, Gaikwad A, Nangude A, Pardeshi G, Kadam D, Gupta A.

BMC Infect Dis. 2018 May 2;18(1):202. doi: 10.1186/s12879-018-3116-7.

28.

Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.

Chabala C, Turkova A, Thomason MJ, Wobudeya E, Hissar S, Mave V, van der Zalm M, Palmer M, Kapasa M, Bhavani PK, Balaji S, Raichur PA, Demers AM, Hoddinott G, Owen-Powell E, Kinikar A, Musoke P, Mulenga V, Aarnoutse R, McIlleron H, Hesseling A, Crook AM, Cotton M, Gibb DM; SHINE trial team.

Trials. 2018 Apr 19;19(1):237. doi: 10.1186/s13063-018-2608-5.

29.

Vector-Borne Disease is a Common Cause of Hospitalized Febrile Illness in India.

Robinson ML, Kadam D, Khadse S, Balasubramanian U, Raichur P, Valvi C, Marbaniang I, Kanade S, Sachs J, Basavaraj A, Bharadwaj R, Kagal A, Kulkarni V, Zenilman J, Nelson G, Manabe YC, Kinikar A, Gupta A, Mave V.

Am J Trop Med Hyg. 2018 May;98(5):1526-1533. doi: 10.4269/ajtmh.17-0571. Epub 2018 Mar 22.

30.

Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.

Nimkar S, Valvi C, Kadam D, Rewari BB, Kinikar A, Gupte N, Suryavanshi N, Deluca A, Shankar A, Golub J, Bollinger R, Gupta A, Marbaniang I, Mave V.

HIV Med. 2018 Jul;19(6):395-402. doi: 10.1111/hiv.12605. Epub 2018 Mar 24.

31.

Cardiovascular risk in an HIV-infected population in India.

Marbaniang IP, Kadam D, Suman R, Gupte N, Salvi S, Patil S, Shere D, Deshpande P, Kulkarni V, Deluca A, Gupta A, Mave V.

Heart Asia. 2017 Jun 30;9(2):e010893. doi: 10.1136/heartasia-2017-010893. eCollection 2017.

32.

Gender-based violence screening methods preferred by women visiting a public hospital in Pune, India.

Suryavanshi N, Naik S, Waghmare S, Gupte N, Khan S, Mave V, Deluca A, Gupta A, Golub J, Bollinger RC, Shankar A.

BMC Womens Health. 2018 Jan 15;18(1):19. doi: 10.1186/s12905-018-0515-2.

33.

Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.

Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte A, Gupta A, Gupte N, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1280-1287. doi: 10.5588/ijtld.17.0474.

34.

The significance of cytomegalovirus in children with pneumonia admitted for mechanical ventilation.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):800-806. doi: 10.5588/ijtld.17.0026.

PMID:
29297442
35.

Secondhand Smoke Exposure and Validity of Self-Report in Low-Income Women and Children in India.

Elf JL, Kinikar A, Khadse S, Mave V, Gupte N, Kulkarni V, Patekar S, Raichur P, Cohen J, Breysse PN, Gupta A, Golub JE.

Pediatrics. 2018 Jan;141(Suppl 1):S118-S129. doi: 10.1542/peds.2017-1026O.

36.

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.

Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M.

PLoS One. 2017 Dec 7;12(12):e0189101. doi: 10.1371/journal.pone.0189101. eCollection 2017.

37.

Antibiotic Utilization and the Role of Suspected and Diagnosed Mosquito-borne Illness Among Adults and Children With Acute Febrile Illness in Pune, India.

Robinson ML, Kadam D, Kagal A, Khadse S, Kinikar A, Valvi C, Basavaraj A, Bharadwaj R, Marbaniang I, Kanade S, Raichur P, Sachs J, Klein E, Cosgrove S, Gupta A, Mave V.

Clin Infect Dis. 2018 May 2;66(10):1602-1609. doi: 10.1093/cid/cix1059.

38.

Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.

Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, Matoga M, Ngongondo M, Samaneka W, Koech L, Naidoo K, Rassool M, Kirui F, Banda P, Mave V, Kadam D, Leger P, Henestroza G, Manabe YC, Bao J, Kumwenda J, Gupta A, Hosseinipour MC; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

AIDS. 2017 Oct 23;31(16):2217-2225. doi: 10.1097/QAD.0000000000001606.

39.

Household food insecurity is associated with low interferon-gamma levels in pregnant Indian women.

Vaidya A, Bhosale R, Sambarey P, Suryavanshi N, Young S, Mave V, Kanade S, Kulkarni V, Deshpande P, Balasubramanian U, Elf J, Gupte N, Gupta A, Mathad JS.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):797-803. doi: 10.5588/ijtld.16.0718.

PMID:
28633705
40.

Tuberculosis screening among persons with diabetes mellitus in Pune, India.

Mave V, Nimkar S, Prasad H, Kadam D, Meshram S, Lokhande R, Gupte N, Jain D, Gupta A, Golub JE.

BMC Infect Dis. 2017 Jun 2;17(1):388. doi: 10.1186/s12879-017-2483-9.

41.

Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission.

Kinikar A, Gupte N, Bhat J, Bharadwaj R, Kulkarni V, Bhosale R, McIntire KN, Mave V, Suryavanshi N, Patil S, Bollinger R, Gupta A.

Sex Transm Dis. 2017 Jun;44(6):371-375. doi: 10.1097/OLQ.0000000000000622.

42.

High Burden of Antimicrobial Resistance and Mortality Among Adults and Children With Community-Onset Bacterial Infections in India.

Mave V, Chandanwale A, Kagal A, Khadse S, Kadam D, Bharadwaj R, Dohe V, Robinson ML, Kinikar A, Joshi S, Raichur P, McIntire K, Kanade S, Sachs J, Valvi C, Balasubramanian U, Kulkarni V, Milstone AM, Marbaniang I, Zenilman J, Gupta A.

J Infect Dis. 2017 Apr 15;215(8):1312-1320. doi: 10.1093/infdis/jix114.

43.

High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.

Kadam D, Chandanwale A, Bharadwaj R, Nevrekar N, Joshi S, Patil S, Gupte N, Sangle S, Chopade K, Kulkarni V, Balasubramanian U, Suryavanshi N, Jain D, Kanade S, Dharmashale S, Kagal A, Gupta A, Mave V.

Indian J Med Microbiol. 2017 Jan-Mar;35(1):105-108. doi: 10.4103/ijmm.IJMM_15_596.

44.

Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.

Shaikh N, Gupte A, Dharmshale S, Pokkali S, Thakar M, Upadhye VJ, Ordonez AA, Kinikar A, Gupte N, Mave V, Kagal A, Gupta A, Lalvani A, Paranjpe R, Bharadwaj R, Jain SK.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):412-419. doi: 10.5588/ijtld.16.0428.

45.

Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.

Gupte N, Kinikar A, McIntire KN, Bhosale R, Patil S, Suryavanshi N, Mave V, Kulkarni V, Bollinger RC, Gupta A.

PLoS One. 2016 Sep 30;11(9):e0162979. doi: 10.1371/journal.pone.0162979. eCollection 2016.

46.

Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.

Mave V, Chandanwale A, Kinikar A, Khadse S, Kagal A, Gupte N, Suryavanshi N, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Joshi S, Horng H, Benet LZ, Ramachandran G, Dooley KE, Gupta A, Gandhi M.

Int J Tuberc Lung Dis. 2016 Jun;20(6):844-7. doi: 10.5588/ijtld.15.0882.

47.

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.

48.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, Smeaton L, Kumarasamy N, Hakim J, Santos B, Riviere C, Hosseinipour MC, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Tripathy S, Mwelase N, Berendes S, Andrade BB, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study Team.

J Infect Dis. 2016 Jul 1;214(1):65-72. doi: 10.1093/infdis/jiw096. Epub 2016 Mar 8.

49.

Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.

Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SV, Kohli R, Gupte N, Thiruvengadam K, Kagal A, Meshram S, Bharadwaj R, Khadse S, Ramachandran G, Hanna LE, Pradhan N, Gomathy NS, DeLuca A, Gupta A, Swaminathan S; CTRIUMPH Study Team.

BMJ Open. 2016 Feb 25;6(2):e010542. doi: 10.1136/bmjopen-2015-010542.

50.

Tuberculosis Risk among Medical Trainees, Pune, India.

Basavaraj A, Chandanwale A, Patil A, Kadam D, Joshi S, Gupte N, McIntire K, Jain D, Dalal H, Badave R, DeLuca A, Gupta A, Bollinger R, Mave V.

Emerg Infect Dis. 2016 Mar;22(3):541-3. doi: 10.3201/eid2203.151673.

Supplemental Content

Support Center